Cargando…

Calculated initial parenteral treatment of bacterial infections: Pharmacokinetics and pharmacodynamics

This is the third chapter of the guideline “Calculated initial parenteral treatment of bacterial infections in adults – update 2018” in the 2(nd) updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Derendorf, Hartmut, Heinrichs, Tobias, Reimers, Tobias, Lebert, Cordula, Brinkmann, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	German Medical Science GMS Publishing House 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186811/ https://www.ncbi.nlm.nih.gov/pubmed/32373442 http://dx.doi.org/10.3205/id000061

Ejemplares similares

Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty
por: Stahlmann, Ralf, et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Respiratory infections
por: Ott, Sebastian R., et al.
Publicado: (2020)

Calculated initial parenteral treatment of bacterial infections: Bacterial endocarditis
por: Dohmen, Pascal M., et al.
Publicado: (2020)

Calculated initial parenteral treatment of bacterial infections: Sepsis
por: Bodmann, Klaus-Friedrich, et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Microbiology
por: Kresken, Michael, et al.
Publicado: (2020)

Calculated initial parenteral treatment of bacterial infections: Bacterial gastrointestinal infections
por: Mutters, Reinier, et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Introduction and antibiotics
por: Bodmann, Klaus-Friedrich, et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Bone and joint infections
por: Vossen, Mathias G., et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Intra-abdominal infections
por: Eckmann, Christian, et al.
Publicado: (2020)

Calculated parenteral initial therapy of bacterial infections: Bacterial meningitis
por: Shah, Pramod M., et al.
Publicado: (2020)

Calculated parenteral initial therapy of bacterial infections: Antibiotic treatment in the elderly
por: Walger, Peter, et al.
Publicado: (2020)

Calculated initial parenteral treatment of bacterial infections: Skin and soft tissue infections
por: Sunderkötter, Cord, et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Economic aspects of antibiotic treatment
por: Wilke, Michael, et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Infections of the kidneys and the genito-urinary tract
por: Fünfstück, Reinhard, et al.
Publicado: (2020)

Electroencephalogram-based pharmacodynamic measures: a review
por: Bewernitz, Michael, et al.
Publicado: (2012)

Calculated parenteral initial treatment of bacterial infections: Infections in the ear, nose, throat and mouth and jaw area
por: Olzowy, Bernhard, et al.
Publicado: (2020)

Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections
por: Wang-Lin, Shun Xin, et al.
Publicado: (2018)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

S2k guideline “Calculated parenteral initial treatment of bacterial infections in adults – update 2018”, 2(nd) updated version: Foreword
por: Bodmann, Klaus-Friedrich, et al.
Publicado: (2020)

Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection
por: Kawaguchi, Nao, et al.
Publicado: (2021)

Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose‐escalating trial
por: Buchtele, Nina, et al.
Publicado: (2020)

Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation
por: Gong, Inna Y., et al.
Publicado: (2011)

Calculated parenteral initial treatment of bacterial infections: Infections with multi-resistant Gram-negative rods – ESBL producers, carbapenemase-producing Enterobacteriaceae, carbapenem-resistant Acinetobacter baumannii
por: Grabein, Béatrice, et al.
Publicado: (2020)

Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen
por: Kato, Hideo, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis
por: Zhang, Cindy X., et al.
Publicado: (2022)

Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model
por: Abla, Nada, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Posaconazole
por: Chen, Lu, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
por: McCarthy, Matthew William
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022)

Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole
por: Barbour, April, et al.
Publicado: (2010)

Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab
por: Tang, Weifeng, et al.
Publicado: (2023)

A Comprehensive Review of the Pharmacodynamics, Pharmacokinetics, and Clinical Effects of the Neutral Endopeptidase Inhibitor Racecadotril
por: Eberlin, Marion, et al.
Publicado: (2012)

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
por: Matsumoto, Kazuaki, et al.
Publicado: (2016)

The Pharmacokinetics and Pharmacodynamics of Iron Preparations
por: Geisser, Peter, et al.
Publicado: (2011)

Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
por: Chen, Nianhang, et al.
Publicado: (2016)

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
por: Wasmann, Roeland E., et al.
Publicado: (2017)

Clinical Pharmacokinetics and Pharmacodynamics of Propofol
por: Sahinovic, Marko M., et al.
Publicado: (2018)

Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
por: Wind, Sven, et al.
Publicado: (2019)

Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib
por: Black, Donald M., et al.
Publicado: (2018)

Clinical Pharmacokinetics and Pharmacodynamics of Afatinib
por: Wind, Sven, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7a0mtsmkjhouu26qlmivcdftf6